83 related articles for article (PubMed ID: 21176738)
21. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
[TBL] [Abstract][Full Text] [Related]
22. The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil.
Matsuoka K; Tsukuda K; Suda M; Kobayashi K; Ota T; Okita A; Watanabe K; Suzuki E; Murakami M; Doihara H; Shimizu N
Int J Oncol; 2004 Jan; 24(1):217-22. PubMed ID: 14654960
[TBL] [Abstract][Full Text] [Related]
23. [Establishment of a multidrug-resistant cell line BEL-7402/5-FU of human hepatocellular carcinoma and its biological characteristics].
Gu W; Zhang YN; Li B; Han J; Cheng BB; Ling CQ
Zhong Xi Yi Jie He Xue Bao; 2006 May; 4(3):265-70. PubMed ID: 16696913
[TBL] [Abstract][Full Text] [Related]
24. [Morphological changes in human colon carcinoma after chemotherapy with 5-fluorouracil--a study in the nude mouse model].
Lohwasser S; Ernst H; Hahn EG; Gossner L; Ell C
Z Gastroenterol; 1997 May; 35(5):319-26. PubMed ID: 9265392
[TBL] [Abstract][Full Text] [Related]
25. An in vitro short time-high dose drug exposure assay for predicting 5FU-resistance of colorectal cancer.
Fan CW; Fan HA; Hsu SH; Chan CC; Chen SY; Hsu YH; Chan EC
Cancer Lett; 2004 Oct; 214(2):181-8. PubMed ID: 15363544
[TBL] [Abstract][Full Text] [Related]
26. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.
Chu E; Drake JC; Koeller DM; Zinn S; Jamis-Dow CA; Yeh GC; Allegra CJ
Mol Pharmacol; 1991 Feb; 39(2):136-43. PubMed ID: 1704999
[TBL] [Abstract][Full Text] [Related]
27. Endoplasmic reticulum stress induces 5-fluorouracil resistance in human colon cancer cells.
Kim JK; Kang KA; Piao MJ; Ryu YS; Han X; Fernando PM; Oh MC; Park JE; Shilnikova K; Boo SJ; Na SY; Jeong YJ; Jeong SU; Hyun JW
Environ Toxicol Pharmacol; 2016 Jun; 44():128-33. PubMed ID: 27163731
[TBL] [Abstract][Full Text] [Related]
28. Effect of HIF-1 modulation on the response of two- and three-dimensional cultures of human colon cancer cells to 5-fluorouracil.
Ravizza R; Molteni R; Gariboldi MB; Marras E; Perletti G; Monti E
Eur J Cancer; 2009 Mar; 45(5):890-8. PubMed ID: 19171477
[TBL] [Abstract][Full Text] [Related]
29. Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin.
Mariadason JM; Arango D; Shi Q; Wilson AJ; Corner GA; Nicholas C; Aranes MJ; Lesser M; Schwartz EL; Augenlicht LH
Cancer Res; 2003 Dec; 63(24):8791-812. PubMed ID: 14695196
[TBL] [Abstract][Full Text] [Related]
30. Regrowth of 5-fluorouracil-treated human colon cancer cells is prevented by the combination of interferon gamma, indomethacin, and phenylbutyrate.
Huang Y; Horvath CM; Waxman S
Cancer Res; 2000 Jun; 60(12):3200-6. PubMed ID: 10866311
[TBL] [Abstract][Full Text] [Related]
31. Cell fusion promotes chemoresistance in metastatic colon carcinoma.
Carloni V; Mazzocca A; Mello T; Galli A; Capaccioli S
Oncogene; 2013 May; 32(21):2649-60. PubMed ID: 22751128
[TBL] [Abstract][Full Text] [Related]
32. Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5-FU) on growth of the colon cancer cell line Caco-2.
Jordan A; Stein J
Eur J Nutr; 2003 Dec; 42(6):324-31. PubMed ID: 14673605
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks.
Wang W; McLeod HL; Cassidy J; Collie-Duguid ES
Cancer Chemother Pharmacol; 2007 May; 59(6):839-45. PubMed ID: 17119966
[TBL] [Abstract][Full Text] [Related]
34. Role of retinoblastoma protein and E2F-1 transcription factor in the acquisition of 5-fluorouracil resistance by colon cancer cells.
Obama K; Kanai M; Kawai Y; Fukushima M; Takabayashi A
Int J Oncol; 2002 Aug; 21(2):309-14. PubMed ID: 12118326
[TBL] [Abstract][Full Text] [Related]
35. 5-Fluorouracil efficiently enhanced apoptosis induced by adenovirus-mediated transfer of caspase-8 in DLD-1 colon cancer cells.
Uchida H; Shinoura N; Kitayama J; Watanabe T; Nagawa H; Hamada H
J Gene Med; 2003 Apr; 5(4):287-99. PubMed ID: 12692863
[TBL] [Abstract][Full Text] [Related]
36. Markers of drug resistance in relapsing colon cancer.
Lazaris AC; Kavantzas NG; Zorzos HS; Tsavaris NV; Davaris PS
J Cancer Res Clin Oncol; 2002 Feb; 128(2):114-8. PubMed ID: 11862483
[TBL] [Abstract][Full Text] [Related]
37. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595
[TBL] [Abstract][Full Text] [Related]
38. [Effects of expression of thymidine phosphorylase induced by gamma-interferon on regulation of antineoplastic activity of fluorouracil on colonic cancer].
Yu XQ; Deng CS; Zhu YQ; Cheng FZ
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):568-70. PubMed ID: 15949342
[No Abstract] [Full Text] [Related]
39. Cytotoxins and cancer immunotherapy: the dance of the macabre?
Allegra CJ; Childs RW
J Natl Cancer Inst; 2005 Oct; 97(19):1396-7. PubMed ID: 16204684
[No Abstract] [Full Text] [Related]
40. Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols.
De Angelis PM; Kravik KL; Tunheim SH; Haug T; Reichelt WH
Mol Cancer; 2004 Apr; 3():11. PubMed ID: 15109396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
